← All organizations
Highest phase reached
Phase 2
First clinical trial
Sep 1, 2010Last known activity
Jul 30, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 3 trials)
Phase 2 (1 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Recent trials (7)
- NCT06529055OfficialN/AJul 30, 2024
- NCT06529055Lead sponsorN/AJul 30, 2024
- NCT06529055Sponsor investigatorN/AJul 30, 2024
- NCT05651243Lead sponsorN/ADec 20, 2022
- NCT05651243Overall official - principal investigatorN/ADec 20, 2022
- NCT05651243Reponsible party - principal investigatorN/ADec 20, 2022
- NCT01103180CollaboratorPhase 2Sep 1, 2010
Details
- Last known activity
- Jul 30, 2024